Medgenome Logo
Prima Logo
MedGenome cordially invites you to a webinar on
An Oncologist's perspective
Date & Time:
26th June, 4:00 PM
Register here

5-20% of all cancer cases are hereditary. Some individuals who carry a harmful genetic mutation are at an increased lifetime risk of developing hereditary breast and ovarian cancer syndrome. Genetic test results can help in treatment in newly diagnosed breast cancer patients and management in survivors and unaffected women.

Multigene panel testing can help identify the mutations present in other genes over and above BRCA1 and BRCA2 which also play a role in development of hereditary cancers.

Dr. Amit Verma
Senior Consultant, Molecular Oncology at
Max Hospitals,Delhi and Gurgaon
Through this webinar, the following points will be addressed
  • Genetics and hereditary breast and ovarian cancer syndrome
  • Multigene panel testing vs single gene testing
  • Consensus guidelines by American Society of Breast Surgeons
  • Case studies
Register Now
Can't attend live?
You can still REGISTER!
We will share the recording of
the webinar with all registrants.
Call in or send us your questions in advance and our
experts will address them in this live session.